Dmitry Balyasny’s PhenomeX Inc. Common Stock CELL Stock Holding History

Dmitry Balyasny’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,282	Closed	-$34.2K	–	3044
2023 Q3	$34.2K	Buy	34,282 +18,792	+121%	+$14.4K	﹤0.01%	2167
2023 Q2	$7.59K	Buy	+15,490	New	+$12.7K	﹤0.01%	2189
2022 Q1	–	Sell	-16,827	Closed	-$306K	–	2983
2021 Q4	$306K	Buy	+16,827	New	+$363K	﹤0.01%	1738

Dmitry Balyasny's CELL Position: Q4 2023 in Review

Dmitry Balyasny sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 34,282 shares — an estimated $34.2K sold.

Dmitry Balyasny first reported a position in CELL in Q4 2021 and held it in 3 quarters. The position peaked at $306K in Q4 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

Dmitry Balyasny reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Dmitry Balyasny sold 34,282 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $34.2K.
Dmitry Balyasny first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Dmitry Balyasny's PhenomeX Inc. Common Stock position peaked at $306K in Q4 2021.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Balyasny Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.